Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
Human papillomavirus (HPV)
NITAG documentation
2016
Clear all
Type of publications
NITAG documentation
(14)
Reports
(1)
Systematic reviews (SYSVAC)
(24)
Topics
Agenda & Minutes
(4)
Background paper
(9)
Recommendation
(1)
Regions
Americas
(12)
Europe
(1)
Western Pacific
(1)
Countries
Argentina
(2)
Australia
(1)
United Kingdom
(1)
United States of America
(10)
Diseases
Human papillomavirus (HPV)
(14)
Cholera
(3)
Dengue
(1)
Diphtheria
(5)
Hepatitis A
(1)
Influenza
(16)
Japanese encephalitis
(2)
Malaria
(3)
Meningococcal disease
(12)
Pertussis
(1)
Pneumococcal disease
(3)
Poliomyelitis
(2)
Rotavirus
(4)
Smallpox
(2)
Yellow fever
(1)
Publication date
2016
(14)
2023
(4)
2022
(12)
2020
(6)
2019
(10)
2018
(18)
2017
(29)
2015
(17)
2014
(17)
2013
(8)
2012
(2)
2011
(6)
2010
(8)
2009
(5)
2008
(6)
2007
(4)
Target population
Available to download in languages
English (EN)
(12)
Spanish (ES)
(2)
14 results found
2016
∙
CoNaIn
Minutes of the third CoNaIn meeting
2016
∙
CoNaIn
Second CoNaIn Meeting minutes
2016
∙
Lauri Markowitz, Allison Kempe, Elissa Meites
Use of a 2-Dose Schedule for Human Papillomavirus Vaccination — Updated Recommendations of the Advisory Committee on Immunization Practices
2016
∙
Lauri Markowitz
2-dose HPV Vaccination Schedules Background
2016
∙
Lauri Markowitz
2-dose Vaccination Schedules Bivalent and Quadrivalent HPV Vaccines
2016
∙
ATAGI
ATAGI Bulletin 59th: 18-19 February 2016
2016
∙
Marc Brisson
Comparing 2- and 3-dose 9-valent HPV Vaccine Schedules in the U.S.: A Cost-effectiveness Analysis
2016
∙
Alain Luxembourg
Comparison of immunogenicity of 2-dose and 3-dose regimens of 9-valent HPV vaccine
2016
∙
Lauri Markowitz
Considerations for Recommendations ACIP HPV Vaccines Work Group
2016
∙
Elissa Meites
GRADE process for 2-dose schedules
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register